Online citations, reference lists, and bibliographies.

Advances On The Formulation Of Proteins Using Nanotechnologies

Irene Santalices, Andrea Gonella, Dolores Torres, M. Alonso
Published 2017 · Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
Abstract Therapeutic proteins and peptides are very attractive from the pharmaceutical point of view due to their high potency and selectivity. Nonetheless, their instability and low bioavailability make their administration through non parenteral routes very difficult, a fact that hampers their efficient exploitation in therapeutics. Since the 70's, significant amount of research in the area of drug delivery and nanotechnology has been done with the final goal of overcoming those hurdles. In particular, biodegradable and biocompatible lipid and polymer-based nanocarriers have emerged as promising delivery platforms to enable the administration of proteins and peptides. This review provides an overview of the mostly explored nanotechnologies to date intended to produce lipidic and polymeric nanocarriers for protein/peptide delivery. The basic principles of the different techniques are discussed, and the main factors involved in the drug association and release, are analyzed. Finally, a brief overview of the potential applications of these protein/peptide-loaded nanocarriers, highlighting the nanomedicines that have reached the market or the clinical development phase, is provided.
This paper references
10.1021/cr200157d
Hydrogels for protein delivery.
T. Vermonden (2012)
10.1016/J.JCONREL.2007.03.012
Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody.
P. Kocbek (2007)
10.1208/pt0804098
Designing chitosan-dextran sulfate nanoparticles using charge ratios
Y. Chen (2008)
Nanocapsule technology: a 1693 review
P. Couvreur (2002)
Stability 2062 and bioactivity of nanocomplex of TNF-related apoptosis-inducing ligand
S. J. Na (2008)
10.1016/j.addr.2016.02.004
Current status of selected oral peptide technologies in advanced preclinical development and in clinical trials.
T. A. Aguirre (2016)
10.1016/0378-5173(94)00272-7
Particle size determination of phase-inverted water-in-oil microemulsions under different dilution and storage conditions
P. P. Constantinides (1995)
FDA’s regulatory science program for generic PLA/PLGA-based 1817 drug products
Y. Wang (2016)
10.1208/aapsj060433
A novel method for the determination of biliary clearance in humans
G. Ghibellini (2008)
Solid lipid nanoparticles (SLN) for controlled drug delivery - 1517 a review of the state of the art
R. H. Müller
Layer-by-layer surface modification of 1673 lipid nanocapsules
S. Hirsjärvi (2010)
10.1016/j.ejps.2012.06.020
Methylated N-(4-N,N-dimethylaminobenzyl) chitosan coated liposomes for oral protein drug delivery.
Jariya Kowapradit (2012)
Alginate/chitosan 2065 nanoparticles are effective for oral insulin delivery
B. Sarmento (2007)
Polymer-based nanoparticles for 1960 protein delivery: design, strategy and applications
H Zhao (1961)
Novel 1868 approach for delivery of insulin loaded poly(lactide-co-glycolide) nanoparticles using a 1869 combination of stabilizers
P. S. Kumar (2007)
hyaluronate/protamine polyelectrolyte nanoplexes: synthesis, stability, biocompatibility 2037 and potential use as peptide carriers
(2014)
10.1248/CPB.52.1273
Influence of the homogenisation procedure on the physicochemical properties of PLGA nanoparticles.
J. Vandervoort (2004)
10.3109/03639045.2014.972412
In vitro lipolysis tests on lipid nanoparticles: comparison between lipase/co-lipase and pancreatic extract
V. Jannin (2015)
Nanoparticles as carriers for growth 1696 hormone releasing factors
J. L. Grangier (1697)
10.1002/smll.201303433
Topical delivery of Avastin to the posterior segment of the eye in vivo using annexin A5-associated liposomes.
Benjamin M. Davis (2014)
10.1016/J.IJPHARM.2006.08.002
In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin.
A. Pardakhty (2007)
10.1016/J.JCONREL.2004.07.030
Transmucosal macromolecular drug delivery.
C. Prego (2005)
10.1016/J.IJPHARM.2006.06.040
Novel O-palmitoylscleroglucan-coated liposomes as drug carriers: development, characterization and interaction with leuprolide.
M. Carafa (2006)
10.1007/S00396-009-2131-Z
Protein-loaded PLGA–PEO blend nanoparticles: encapsulation, release and degradation characteristics
M. J. Santander-Ortega (2010)
10.1016/j.ejpb.2015.04.013
Effective incorporation of insulin in mucus permeating self-nanoemulsifying drug delivery systems.
T. Karamanidou (2015)
Lipid-based colloidal carriers for peptide and protein delivery – liposomes versus lipid nanoparticles
S. Martins (2007)
10.1208/pt060474
Nanoprecipitation versus emulsion-based techniques for the encapsulation of proteins into biodegradable nanoparticles and process-related stability issues
U. Bilati (2008)
Method for the preparation of nanoparticles from 1607 nenoemulsions
S. Magdassi (2011)
Liposomes 1416 and other vesicular systems: structural characteristics
E. Elizondo (2011)
Bioavailability and pharmacokinetics of cyclosporine formulations: Neoral® vs 2117 Sandimmune®
M. G. Choc (1997)
Current 1309 status of selected oral peptide technologies in advanced preclinical development and in 1310 clinical trials
T.A.S. Aguirre (2016)
Surface-modified P(HEMAco-MAA) nanogel carriers for oral vaccine delivery: design
M. Durán-Lobato (2014)
10.1248/CPB.58.1423
Chitosan nanoparticles: a promising system in novel drug delivery.
K. Nagpal (2010)
10.14314/POLIMERY.2013.858
Polyesters and polyester carbonates for controlled drug delivery. Part II. Implantable systems
K. Jelonek (2013)
10.1515/9783111697888-004
B
B. A. R. Kernfach (1824)
Food-grade nanoemulsions: formulation
D. J. McClements (2011)
10.1007/s003960050050
Development of positively charged colloidal drug carriers: Chitosan-coated polyester nanocapsules and submicron-emulsions
P. Calvo (1997)
10.1016/J.PROGPOLYMSCI.2011.01.001
Polymer nanoparticles: Preparation techniques and size-control parameters
J. D. Rao (2011)
10.1371/journal.pone.0062500
A Polymer/Oil Based Nanovaccine as a Single-Dose Immunization Approach
S. Vicente (2013)
10.2337/diab.37.2.246
New Approach for Oral Administration of Insulin With Polyalkylcyanoacrylate Nanocapsules as Drug Carrier
C. Damgé (1988)
Nanocapsules as 1771 carriers for oral peptide delivery
C. Damge (1772)
The effect of site of 1767 administration in the gastrointestinal tract on the absorption of insulin from nanocapsules 1768 in diabetic rats
C. Michel (1991)
Biodegradable poly (D,L-lactic-co-glycolic acid)- 1814 based micro/nanoparticles for sustained release of protein drugs - A review, Trop
R. H. Ansary (2014)
Formulation of L-asparaginaseloaded poly(lactide-co-glycolide) nanoparticles: influence of polymer properties on enzyme loading
M. M. Gaspar (1016)
10.1016/j.ijpharm.2012.02.035
Development and characterisation of chitosan films impregnated with insulin loaded PEG-b-PLA nanoparticles (NPs): a potential approach for buccal delivery of macromolecules.
Concetta Giovino (2012)
10.1016/J.JCIS.2005.03.063
Synthesis and characterization of polyacrylonitrile nanoparticles by dispersion/emulsion polymerization process.
L. Boguslavsky (2005)
10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4
Novel hydrophilic chitosan‐polyethylene oxide nanoparticles as protein carriers
P. Calvo (1997)
10.1080/10717540801905165
Polyelectrolyte Biomaterial Interactions Provide Nanoparticulate Carrier for Oral Insulin Delivery
C. Reis (2008)
Method for producing solid lipid microspheres having a narrow size 1336 distribution
M. R. Gasco (1993)
Ritthidej, Poly(α-butyl cyanoacrylate) 1912 nanoparticles for intracellular delivery of protein: physicochemical properties, cytotoxicity 1913 study and cellular uptake in dendritic cells
C. Kusonwiriyawong (2008)
10.1016/S0378-5173(99)00417-2
Influence of high pressure homogenisation equipment on nanodispersions characteristics.
S. Liedtke (2000)
10.1016/S0169-409X(03)00041-3
Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications.
C. Vauthier (2003)
10.1038/nnano.2012.168
Microfluidic technologies for accelerating the clinical translation of nanoparticles.
P. Valencia (2012)
10.1615/CRITREVTHERDRUGCARRIERSYST.2013006475
Poly(lactic-co-glycolic) acid-controlled-release systems: experimental and modeling insights.
D. J. Hines (2013)
10.2174/0929866521666140807114240
Recent advances in protein and Peptide drug delivery: a special emphasis on polymeric nanoparticles.
Ashaben Patel (2014)
10.1039/c5nr04867b
Anti-HER2/neu peptide-conjugated iron oxide nanoparticles for targeted delivery of paclitaxel to breast cancer cells.
Qingxin Mu (2015)
10.1016/j.geb.2003.09.006
Preparation
M. Voorneveld (2004)
10.1080/03639040802130061
Lipid nanoparticles with a solid matrix (SLN, NLC, LDC) for oral drug delivery.
M. Muchow (2008)
10.2217/nnm.10.30
Enhanced binding and killing of target tumor cells by drug-loaded liposomes modified with tumor-specific phage fusion coat protein.
T. Wang (2010)
10.2307/j.ctvrnfqk1.10
? ? ? ? f ? ? ? ? ?
A. ADoefaa (2003)
Solid lipid nanoparticles as a drug delivery system for peptides and 1564 proteins
A. J. Almeida (2007)
Mucosal delivery of 1491 liposome-chitosan nanoparticle complexes, in: Methods Enzymol
E.L.S. Carvalho (2009)
Protein 1341 encapsulation within polyethylene glycol-coated nanospheres. I. Physicochemical 1342 characterization
P Quellec (1998)
Pharmaceutical cyclosporin formulation 1526 with improved biopharmaceutical properties, improved physical quality and greater 1527 stability, and method for producing said formulation
L J Penkler (2003)
10.1007/s11095-007-9367-4
Alginate/Chitosan Nanoparticles are Effective for Oral Insulin Delivery
B. Sarmento (2007)
10.1089/jamp.2007.0667
Increased biological half-life of aerosolized liposomal recombinant human Cu/Zn superoxide dismutase in pigs.
Martin Kaipel (2008)
ORAL PEPTIDE DELIVERY : TECHNOLOGY LANDSCAPE & CURRENT STATUS
(2015)
10.1016/S0939-6411(00)00087-4
Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.
R. Mueller (2000)
10.1016/j.ultsonch.2009.02.008
Minimising oil droplet size using ultrasonic emulsification.
T. Leong (2009)
10.1016/S0022-2836(64)80115-7
NEGATIVE STAINING OF PHOSPHOLIPIDS AND THEIR STRUCTURAL MODIFICATION BY SURFACE-ACTIVE AGENTS AS OBSERVED IN THE ELECTRON MICROSCOPE.
A. Bangham (1964)
10.1016/J.IJPHARM.2004.12.030
New surface-modified lipid nanoparticles as delivery vehicles for salmon calcitonin.
M. Garcia-Fuentes (2005)
10.4155/tde.13.46
Nanoemulsion-based oral delivery systems for lipophilic bioactive components: nutraceuticals and pharmaceuticals.
D. J. Mcclements (2013)
Particle size determination of phase-inverted water-in-oil 1655 microemulsions under different dilution and storage conditions
P. P. Constantinides
10.1016/J.POLYMDEGRADSTAB.2008.04.012
Synthesis and degradation behavior of poly(ethyl cyanoacrylate)
M. G. Han (2008)
10.1016/0378-5173(89)90281-0
Nanocapsule formation by interfacial polymer deposition following solvent displacement
H. Fessi (1989)
Review on Polyelectrolyte Complex as Novel Approach for Drug Delivery System
S. Patwekar (2016)
10.1002/jps.2600651217
Polymerized micelles and their use as adjuvants in immunology.
G. Birrenbach (1976)
10.1021/bm800975j
New generation of hybrid poly/oligosaccharide nanoparticles as carriers for the nasal delivery of macromolecules.
D. Teijeiro-Osorio (2009)
Solid lipid nanoparticles: production
W. Mehnert
10.1002/jps.21434
Production of solid lipid submicron particles for protein delivery using a novel supercritical gas-assisted melting atomization process.
S. Salmaso (2009)
10.1016/j.jcis.2012.08.069
Fabrication of vitamin E-enriched nanoemulsions: factors affecting particle size using spontaneous emulsification.
A. H. Saberi (2013)
10.1016/J.FOODHYD.2010.09.017
Formation of nanoemulsions stabilized by model food-grade emulsifiers using high-pressure homogenization: Factors affecting particle size
Cheng Qian (2011)
10.1016/j.ejpb.2010.12.008
In vitro and in vivo evaluation of WGA-carbopol modified liposomes as carriers for oral peptide delivery.
Abdallah Makhlof (2011)
10.1016/j.drudis.2016.04.002
Modern approaches to the ocular delivery of cyclosporine A.
P. Agarwal (2016)
10.1186/1556-276X-9-340
Preparation and nanoencapsulation of l-asparaginase II in chitosan-tripolyphosphate nanoparticles and in vitro release study
E. Bahreini (2014)
10.1021/acsami.7b00810
Noncovalent Protein and Peptide Functionalization of Single-Walled Carbon Nanotubes for Biodelivery and Optical Sensing Applications.
Alessandra Antonucci (2017)
10.1517/17425247.2012.735658
Liposomal delivery of proteins and peptides
Janani Swaminathan (2012)
10.1002/APP.12016
Depolymerized chitosan nanoparticles for protein delivery: Preparation and characterization
Kevin A. Janes (2003)
10.1039/C5TB01760B
A versatile pH-responsive platform for intracellular protein delivery using calcium phosphate nanoparticles.
B. Zeng (2015)
10.1016/J.EURPOLYMJ.2017.03.049
Solvent-free protamine nanocapsules as carriers for mucosal delivery of therapeutics
Paulina Jakubiak (2017)
CHITOSAN NANOPARTICLES: A PROMISING SYSTEM FOR DRUG DELIVERY
W. Tiyaboonchai (2003)
10.1016/S1773-2247(06)50061-9
Chitosan nanocapsules: a new carrier for nasal peptide delivery
C. Prego (2006)
Oral 1569 bioavailability of cyclosporine: solid lipid nanoparticles (SLN®) versus drug nanocrystals, Int. 1570
R H Müller (2006)
W/O/W multiple emulsions of insulin 1637 containing a protease inhibitor and an absorption enhancer: preparation
A. Silva-Cunha
Dry powders of stable protein 1543 formulations from aqueous solutions prepared using supercritical CO2-assisted 1544 aerosolization
S. P. Sellers (2001)
10.1016/S0378-5173(02)00175-8
Absorption and efficiency of insulin after oral administration of insulin-loaded nanocapsules in diabetic rats.
F. Cournarie (2002)
10.1016/j.vaccine.2009.05.029
Eleven years of Inflexal V-a virosomal adjuvanted influenza vaccine.
C. Herzog (2009)
1507 Preparation
N. Arulsudar (2004)
10.1016/S0927-7765(99)00157-5
The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration.
Tobío (2000)
10.1007/s11095-008-9800-3
Methods for the Preparation and Manufacture of Polymeric Nanoparticles
C. Vauthier (2008)
10.1002/jps.21347
Nanoparticulate biopolymers deliver insulin orally eliciting pharmacological response.
C. Reis (2008)
10.1016/J.JCONREL.2013.03.037
A new potential nano-oncological therapy based on polyamino acid nanocapsules.
Teresa Gonzalo (2013)
10.1088/0957-4484/25/24/245101
Delivery of proteins to mammalian cells via gold nanoparticle mediated laser transfection.
D. Heinemann (2014)
10.1021/bm401580k
Improved stability and antidiabetic potential of insulin containing folic acid functionalized polymer stabilized multilayered liposomes following oral administration.
A. Agrawal (2014)
10.1515/9783111413426-013
L
Il Liceo (1824)
10.1016/S0378-5173(01)00579-8
Liposomes with phosphatidylethanol as a carrier for oral delivery of insulin: studies in the rat.
M. Kisel (2001)
10.1039/C0SM00862A
Nanoprecipitation and nanoformulation of polymers: from history to powerful possibilities beyond poly(lactic acid)
S. Schubert (2011)
1986 Hyaluronic acid nanohydrogels as a useful tool for BSAO immobilization in the treatment of 1987 melanoma cancer cells
E. Montanari (2013)
10.1208/s12248-012-9339-4
Challenges in Development of Nanoparticle-Based Therapeutics
N. Desai (2012)
10.1016/J.IJPHARM.2006.02.045
Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals.
R. Mueller (2006)
10.1016/S0168-3659(97)00106-5
Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method.
M. Zambaux (1998)
Preparation of submicron drug particles in lecithin-stabilized 1532 o/w emulsions I
B. Sjöström
Particle size and size distribution of poly(butyl-2- 1934 cyanoacrylate) nanoparticles I
S. J. Douglas
D-arginine vasopressin after various routes of administration in healthy volunteers
N-dimethylaminobenzyl) chitosan coated liposomes for oral protein 1473 drug delivery
N- Methylated (2012)
Solid lipid nanoparticles (SLN) for 1514 controlled drug delivery
C. Schwarz
Nanoparticles as carriers for 1947 growth hormone releasing factors (GRF)
J L Grangier (1991)
10.3390/molecules14093754
Nasal Delivery of High Molecular Weight Drugs
Y. Ozsoy (2009)
10.1039/c002866e
PLGA micro/nanosphere synthesis by droplet microfluidic solvent evaporation and extraction approaches.
Lung-Hsin Hung (2010)
Formulation of lipid-based delivery systems for oral 1628 administration: materials
C. W. Pouton (2008)
Liposome: method of preparation and applications
J. S. Dua (2012)
Particle size and size distribution of poly(butyl-2cyanoacrylate) nanoparticles I
S. J. Douglas (1016)
10.1016/J.IJPHARM.2003.12.016
Preparation and characterization of solid lipid nanoparticles containing peptide.
F. Hu (2004)
10.1016/j.rinphs.2012.11.001
Two-step nanoprecipitation for the production of protein-loaded PLGA nanospheres
Moraima Morales-Cruz (2012)
10.1016/j.actbio.2016.11.011
Comparative evaluation of polycyanoacrylates.
Yoav Barkan (2017)
10.1080/02652040601162335
Preparation and release characteristics of insulin and insulin-like growth factor-one from polymer nanoparticles
J. G. Eley (2007)
10.1016/S0378-5173(03)00055-3
Insulin containing polyethylenimine-dextran sulfate nanoparticles.
W. Tiyaboonchai (2003)
10.1016/J.JCONREL.2008.09.043
Poly(α-butyl cyanoacrylate) nanoparticles for intracellular delivery of protein: Physicochemical properties, cytotoxicity study and cellular uptake in dendritic cells
C. Kusonwiriyawong (2008)
10.5040/9781474284028.0024
S
A. Kumar (1824)
Krenn V
K. Mg (2015)
10.1016/S0169-409X(01)00105-3
Solid lipid nanoparticles: production, characterization and applications.
W. Mehnert (2001)
10.1016/j.ijpharm.2008.07.013
Stability and bioactivity of nanocomplex of TNF-related apoptosis-inducing ligand.
S. J. Na (2008)
10.1007/s11095-006-9570-8
Efficacy and Mechanism of Action of Chitosan Nanocapsules for Oral Peptide Delivery
C. Prego (2006)
Bioavailability and pharmacokinetics of cyclosporine formulations: Neoral® vs 2117
M G Choc
10.1002/jps.23974
Protein nanoparticles for intracellular delivery of therapeutic enzymes.
L. H. Estrada (2014)
10.1016/S0939-6411(97)00056-8
Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres
M. D. Blanco (1997)
10.1016/J.PROGPOLYMSCI.2014.02.009
Challenges for industrialization of miniemulsion polymerization
J. Asua (2014)
New approach for the preparation of nanoparticles by an emulsification-diffusion method
J. Leroux (1995)
10.3109/03639049209069315
Preparation of Poly(D,L-Lactide/Glycolide) Nanoparticles of Controlled Particle Size Distribution: Application of Experimental Designs
M. Julienne (1992)
10.1080/10408398.2011.559558
Food-Grade Nanoemulsions: Formulation, Fabrication, Properties, Performance, Biological Fate, and Potential Toxicity
D. J. Mcclements (2011)
10.1016/j.ejpb.2010.07.002
Microemulsions for oral delivery of insulin: design, development and evaluation in streptozotocin induced diabetic rats.
G. Sharma (2010)
Insulin-loaded 1841 PLGA nanoparticles for oral administration: an in vitro physico-chemical characterization
M. J. Santander-Ortega (2009)
Method for preparation of orally administrated 1403 insulin formulation
C Zheng (2006)
Pharmaceutical Compositions Containing Insulin
R. C. New (2002)
Method for the preparation of nanoparticles from nenoemulsions
S. Magdassi (2011)
10.1016/0378-5173(95)00057-P
Preparation and characterization of a peptide containing w/o emulsion
Timm Trenktrog (1995)
10.1016/j.ejpb.2015.09.019
Protamine-based nanoparticles as new antigen delivery systems.
J. V. González-Aramundiz (2015)
10.1016/J.IJPHARM.2005.01.018
Investigation of lectin-modified insulin liposomes as carriers for oral administration.
N. Zhang (2005)
10.1021/bm500588x
Surface-modified P(HEMA-co-MAA) nanogel carriers for oral vaccine delivery: design, characterization, and in vitro targeting evaluation.
M. Durán-Lobato (2014)
10.1166/JBN.2014.1878
Self-assembled hyaluronate/protamine polyelectrolyte nanoplexes: synthesis, stability, biocompatibility and potential use as peptide carriers.
A. Umerska (2014)
10.1046/J.1365-2710.2000.00306.X
Oral multiple w/o/w emulsion formulation of a peptide salmon calcitonin: in vitro-in vivo evaluation.
S. Doğru (2000)
10.4314/TJPR.V13I7.24
Biodegradable poly(D,L-lactic-co-glycolic acid)-basedmicro/nanoparticles for sustained release of proteindrugs - a review
R. H. Ansary (2014)
10.1016/S0378-5173(02)00268-5
Incorporation of cyclosporin A in solid lipid nanoparticles (SLN).
E. Ugazio (2002)
10.1211/0022357021778736
In-vitro release and oral bioactivity of insulin in diabetic rats using nanocapsules dispersed in biocompatible microemulsion.
Suchat Watnasirichaikul (2002)
10.1016/J.JCONREL.2005.04.013
Using different structure types of microemulsions for the preparation of poly(alkylcyanoacrylate) nanoparticles by interfacial polymerization.
K. Krauel (2005)
10.1016/j.colsurfb.2008.12.031
Strategic approaches for improving entrapment of hydrophilic peptide drugs by lipid nanoparticles.
Hong Yuan (2009)
10.1517/17425247.2014.917077
Oral peptide and protein delivery: intestinal obstacles and commercial prospects
Alice L Smart (2014)
10.1016/j.ijpharm.2009.12.052
Silk fibroin nanoparticles for cellular uptake and control release.
J. Kundu (2010)
10.4172/2157-7439.1000336
History and Possible Uses of Nanomedicine Based on Nanoparticles and Nanotechnological Progress
M. G. Krukemeyer (2015)
Polyelectrolyte biomaterial 1995 M AN US CR IP T AC CE PT ED ACCEPTED MANUSCRIPT 59 interactions provide nanoparticulate carrier for oral insulin delivery
C. P. Reis (2008)
In 1652 vitro and in vivo evaluation of a water-in-oil microemulsion system for enhanced peptide 1653 intestinal delivery
D. Liu (2013)
Absorption and 1781 efficiency of insulin after oral administration of insulin-loaded nanocapsules in diabetic 1782 rats
F. Cournarie
Strategic approaches for 1540 improving entrapment of hydrophilic peptide drugs by lipid nanoparticles, Colloids Surfaces 1541 B Biointerfaces
H Yuan (2009)
Novel O- 1503 palmitoylscleroglucan-coated liposomes as drug carriers: development
M. Carafa (2006)
10.1021/la901565q
Aqueous-core lipid nanocapsules for encapsulating fragile hydrophilic and/or lipophilic molecules.
N. Anton (2009)
Lipid-based nanocarriers for 1371 M AN US CR IP T AC CE PT ED ACCEPTED MANUSCRIPT 46 the oral administration of biopharmaceutics
T. Karamanidou (2016)
Influence of the homogenisation procedure on the 1851 M AN US CR IP T AC CE PT ED ACCEPTED MANUSCRIPT 56 physicochemical properties of PLGA nanoparticles
J. Vandervoort (2004)
10.1039/c5bm00052a
Protein nanoparticles for therapeutic protein delivery.
L. Herrera Estrada (2015)
10.18433/J3CP55
Liposomal drug delivery: a versatile platform for challenging clinical applications.
Asadullah Madni (2014)
10.1016/S0022-2836(65)80093-6
Diffusion of univalent ions across the lamellae of swollen phospholipids.
A. Bangham (1965)
10.1016/S0378-5173(02)00002-9
Effects of formulation variables on characteristics of poly (ethylcyanoacrylate) nanocapsules prepared from w/o microemulsions.
S. Watnasirichaikul (2002)
10.1016/0378-5173(93)90369-Q
Development of biodegradable microspheres and nanospheres for the controlled release of cyclosporin A
A. Sánchez (1993)
10.1016/S0168-3659(02)00028-7
Preparation of stable insulin-loaded nanospheres of poly(ethylene glycol) macromers and N-isopropyl acrylamide.
W. Leobandung (2002)
10.1016/S0142-9612(00)00286-6
Poly n-butyl cyanoacrylate nanoparticles: a mechanistic study of polymerisation and particle formation.
N. Behan (2001)
10.3980/j.issn.2222-3959.2014.01.01
Effect of intravitreal injection of bevacizumab-chitosan nanoparticles on retina of diabetic rats.
Yan Lu (2014)
10.1080/17425247.2016.1206074
Emerging delivery platforms for mucosal administration of biopharmaceuticals: a critical update on nasal, pulmonary and oral routes
Lungile Nomcebo Thwala (2017)
10.1016/S0021-9797(69)80012-3
The Stability of O/W type emulsions as functions of temperature and the HLB of emulsifiers: The emulsification by PIT-method
K. Shinoda (1969)
10.1016/0021-9797(84)90015-8
Particle size and size distribution of poly(butyl-2-cyanoacrylate) nanoparticles: I. Influence of physicochemical factors
S. J. Douglas (1984)
10.1016/0378-5173(92)90051-3
Preparation of submicron drug particles in lecithin-stabilized o/w emulsions I. Model studies of the precipitation of cholesteryl acetate
B. Sjoestroem (1992)
Insulin in w/o/w multiple emulsions: 1634 preparation
A. S. Cunha (1997)
Zabarovskaya, Liposomes with phosphatidylethanol as a carrier for oral delivery of insulin: 1469 studies in the rat
M. A. Kisel (2001)
10.1016/j.cis.2014.03.009
Preparation methods of alginate nanoparticles.
J. P. Paques (2014)
10.1208/s12248-012-9441-7
In Vitro and In Vivo Evaluation of a Water-in-Oil Microemulsion System for Enhanced Peptide Intestinal Delivery
Dongyun Liu (2012)
Formulation strategies to improve the bioavailability of poorly 1658 absorbed drugs with special emphasis on self-emulsifying systems, ISRN Pharm
S Gupta (2013)
10.1016/j.ijpharm.2011.08.029
Preliminary evaluation of a novel oral delivery system for rhPTH1-34: in vitro and in vivo.
L. Guo (2011)
Emerging delivery platforms for mucosal administration 2096 of biopharmaceuticals: a critical update on nasal
L.N.N. Thwala (2017)
10.1021/mp900043e
Histidine residues in the peptide D-Lys(6)-GnRH: potential for copolymerization in polymeric nanoparticles.
Alexandra P Kafka (2009)
10.1002/bit.22958
Proteins conjugated to poly(butyl cyanoacrylate) nanoparticles as potential neuroprotective agents
Vladimir L. Reukov (2011)
10.1016/S0928-0987(97)86243-4
Solid lipid nanoparticles (SLN) for controlled drug delivery
R. Mueller (1996)
10.1177/193229680800200225
Inhaled Insulin: Promises and Concerns
J. Selam (2008)
10.1166/JNN.2006.429
Chitosan nanocapsules as carriers for oral peptide delivery: effect of chitosan molecular weight and type of salt on the in vitro behaviour and in vivo effectiveness.
C. Prego (2006)
10.1016/j.ijpharm.2013.02.035
Systemic heparin delivery by the pulmonary route using chitosan and glycol chitosan nanoparticles.
A. Trapani (2013)
10.1021/ACS.CHEMMATER.6B04404
Multifunctional Click Hyaluronic Acid Nanogels for Targeted Protein Delivery and Effective Cancer Treatment in Vivo
J. Chen (2016)
10.1248/BPB.35.781
Efficient intradermal delivery of superoxide dismutase using a combination of liposomes and iontophoresis for protection against UV-induced skin damage.
K. Kigasawa (2012)
10.1021/j150580a027
Mechanism of Formation and Structure of Micro Emulsions by Electron Microscopy
J. H. Schulman (1959)
10.1039/C2SM06903B
Nanoemulsions versus microemulsions: terminology, differences, and similarities
D. J. Mcclements (2012)
Poly(alkyl cyanoacrylate) nanocapsules as 1688 a delivery system in the rat for octreotide
C. Damgé (1997)
Novel Opalmitoylscleroglucan-coated liposomes as drug carriers: development
M. Carafa (2006)
10.1016/j.jconrel.2011.08.008
Microencapsulated chitosan nanoparticles for pulmonary protein delivery: in vivo evaluation of insulin-loaded formulations.
S. Al-Qadi (2012)
10.1007/S00396-004-1173-5
In vitro release of protein from poly(butylcyanoacrylate) nanocapsules with an aqueous core
S. Li (2005)
10.1016/J.IJPHARM.2004.09.002
PLA-PEG particles as nasal protein carriers: the influence of the particle size.
A. Vila (2005)
Preparation methods of 1957 alginate nanoparticles
J P Paques (1958)
10.1016/S0378-5173(99)00045-9
Physico-chemical characterization of insulin-loaded poly(isobutylcyanoacrylate) nanocapsules obtained by interfacial polymerization.
M. Aboubakar (1999)
10.4155/tde.14.111
Challenges in the delivery of peptide drugs: an industry perspective.
A. Lewis (2015)
10.1016/j.peptides.2010.10.003
Development of peptide and protein nanotherapeutics by nanoencapsulation and nanobioconjugation
S. C. Yadav (2011)
10.1007/s11095-010-0309-1
Nano-emulsions and Micro-emulsions: Clarifications of the Critical Differences
N. Anton (2010)
10.1016/j.ejps.2008.12.017
Oral insulin delivery using nanoparticles based on microemulsions with different structure-types: optimisation and in vivo evaluation.
A. Graf (2009)
10.3390/POLYM3041972
Water Soluble Polymers for Pharmaceutical Applications
Veeran Gowda Kadajji (2011)
10.1016/j.ijpharm.2009.06.014
Biopharmaceutical characterisation of insulin and recombinant human growth hormone loaded lipid submicron particles produced by supercritical gas micro-atomisation.
S. Salmaso (2009)
10.1016/B978-0-12-384931-1.00018-0
R
J. Lackie (2013)
10.1515/9783111548050-028
Q
Chlorpromazine Thorazine (1824)
Nanomedicine drugs approved and in development
Nanomedicines Alliance (2016)
Physico-chemical characterization of 1774 insulin-loaded poly (isobutylcyanoacrylate) nanocapsules obtained by interfacial 1775 polymerization
M. Aboubakar
10.1016/0378-5173(93)90075-Q
Study of the mechanisms of formation of nanoparticles and nanocapsules of polyisobutyl-2-cyanoacrylate
M. Gallardo (1993)
10.1016/j.ijpharm.2009.07.028
Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery.
N. Csaba (2009)
Liposomes 1416 and other vesicular systems: structural characteristics, methods of preparation, and use in 1417 nanomedicine
E Elizondo (2011)
10.1016/s0076-6879(76)44019-3
Enzyme entrapment in liposomes.
G. Gregoriadis (1976)
10.1517/17425247.2012.673580
Dextran conjugates in drug delivery
J. Varshosaz (2012)
10.1016/j.ijpharm.2009.05.014
The universality of low-energy nano-emulsification.
N. Anton (2009)
10.1023/A:1018908705446
Enhancement of Nasal Absorption of Insulin Using Chitosan Nanoparticles
R. Fernández-Urrusuno (2004)
10.1016/j.ijpharm.2014.05.047
In vivo evaluation of an oral self-microemulsifying drug delivery system (SMEDDS) for leuprorelin.
Fabian Hintzen (2014)
Study of the mechanism of 1754 insulin encapsulation in poly(isobutylcyanoacrylate) nanocapsules obtained by interfacial 1755 M AN US CR IP T AC CE PT ED ACCEPTED MANUSCRIPT 54 polymerization
M. Aboubakar
10.1007/3-540-26367-5_1
A
A. Spring (2005)
10.1016/S0378-5173(01)00614-7
Prolonged hypoglycemic effect of insulin-loaded polybutylcyanoacrylate nanoparticles after pulmonary administration to normal rats.
Q. Zhang (2001)
10.1016/J.JCONREL.2004.10.010
Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions.
H. Yamamoto (2005)
10.1016/J.PROGPOLYMSCI.2011.06.003
Alginate: properties and biomedical applications.
K. Lee (2012)
10.1016/S0939-6411(03)00145-0
Development of acrylic-based copolymers for oral insulin delivery.
Aaron C Foss (2004)
10.1016/0168-3659(94)90047-7
Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization
C. Schwarz (1994)
Study of the mechanism of 1754 insulin encapsulation in poly(isobutylcyanoacrylate) nanocapsules obtained by interfacial 1755 polymerization
M Aboubakar (1999)
Nanoparticles as carriers for 1947 M AN US CR IP T AC CE PT ED ACCEPTED MANUSCRIPT 58 growth hormone releasing factors (GRF)
J. L. Grangier (1991)
Lipid-based 1374 nanocarriers for oral peptide delivery
Z Niu
10.1016/S0939-6411(03)00191-7
Evidence for restrictive parameters in formulation of insulin-loaded nanocapsules.
F. Cournarie (2004)
JR 旅客販売総合システム(マルス)における運用及び管理について
S. Dex (1991)
Polyelectrolyte biomaterial 59 interactions provide nanoparticulate carrier for oral insulin delivery
C. P. Reis (2008)
10.1016/0378-5173(94)90466-9
Incorporation in lipospheres of [d-Trp-6]LHRH
S. Morel (1994)
10.1016/0009-2509(93)80021-H
Principles of emulsion formation
P. Walstra (1993)
10.1016/J.JCONREL.2003.12.021
Self-porating polymersomes of PEG-PLA and PEG-PCL: hydrolysis-triggered controlled release vesicles.
Fariyal Ahmed (2004)
10.1016/J.EJPS.2005.02.008
A comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly(ethylene glycol) as carriers for oral calcitonin delivery.
M. Garcia-Fuentes (2005)
Self-assembled Polyelectrolyte Nanocomplexes of Alginate, Chitosan and Ovalbumin.
Mateja Cegnar (2010)
Solid lipid nanoparticles loaded with insulin by 1561 sodium cholate-phosphatidylcholine-based mixed micelles: preparation and 1562 characterization
J. Liu (2007)
10.1007/s10989-004-2433-4
Chitosan-dextran Sulfate Nanoparticles for Delivery of an Anti-angiogenesis Peptide
Y. Chen (2004)
Method for producing solid lipid microspheres having a narrow size distribution
M. R. Gasco (1993)
10.1016/J.EJPS.2006.12.007
Nanoparticulate delivery system for insulin: design, characterization and in vitro/in vivo bioactivity.
C. Reis (2007)
10.1002/btpr.12
Polyethylenimine‐coated albumin nanoparticles for BMP‐2 delivery
S. Zhang (2008)
10.1111/J.2042-7158.1997.TB06022.X
Poly(alkyl cyanoacrylate) nanocapsules as a delivery system in the rat for octreotide, a long-acting somatostatin analogue.
C. Damgé (1997)
10.1023/A:1007574030674
Preparation of Biodegradable Insulin Nanocapsules from Biocompatible Microemulsions
Suchat Watnasirichaikul (2004)
10.3109/02652049709051135
Insulin in w/o/w multiple emulsions: preparation characterization and determination of stability towards proteases in vitro.
A. Cunha (1997)
Formulation of L-asparaginase- 1861 loaded poly(lactide-co-glycolide) nanoparticles: influence of polymer properties on enzyme 1862 loading
M. M. Gaspar
Influence of the homogenisation procedure on the of PLGA nanoparticles
J Vandervoort (2004)
Self-assembled 2036 hyaluronate/protamine polyelectrolyte nanoplexes: synthesis
A. Umerska (2014)
The effect of temperature on the phase equilibria and the types of 1601 dispersions of the ternary system composed of water
K. Shinoda
10.2147/IJN.S46900
Nanopharmaceuticals (part 1): products on the market
V. Weissig (2014)
10.2165/00003495-199300451-00005
Efficacy and Upper GI Safety of Diclofenac/Misoprostol, Piroxicam and Naproxen in Patients with Osteoarthritis
G. Geis (2012)
10.1177/1932296814524871
A Single-blind, Placebo-controlled, Dose-ranging Trial of Oral Hepatic-directed Vesicle Insulin Add-on to Oral Antidiabetic Treatment in Patients With Type 2 Diabetes Mellitus
W. Geho (2014)
10.1080/10717540701606467
Novel Approach for Delivery of Insulin Loaded Poly(lactide-co-glycolide) Nanoparticles Using a Combination of Stabilizers
P. S. Kumar (2007)
10.1016/0021-9797(68)90273-7
The effect of temperature on the phase equilibria and the types of dispersions of the ternary system composed of water, cyclohexane, and nonionic surfactant
K. Shinoda (1968)
10.1016/b978-0-12-384931-1.00003-9
C
J. Lackie (2013)
10.1016/J.JCONREL.2005.12.015
Chitosan-PEG nanocapsules as new carriers for oral peptide delivery. Effect of chitosan pegylation degree.
C. Prego (2006)
10.1016/j.colsurfb.2013.01.064
Production of BSA-poly(ethyl cyanoacrylate) nanoparticles as a coating material that improves wetting property.
S. Kim (2013)
Nanoemulsions versus microemulsions: terminology
D. J. McClements (2012)
10.1080/01932691003757314
Characterization of Chitosan/Alginate Self-Assembled Nanoparticles as a Protein Carrier
M. Zohri (2011)
10.1164/AJRCCM.156.6.9702101
Tolerance of volunteers to cyclosporine A-dilauroylphosphatidylcholine liposome aerosol.
B. Gilbert (1997)
10.1002/JPS.1032
Dry powders of stable protein formulations from aqueous solutions prepared using supercritical CO(2)-assisted aerosolization.
S. Sellers (2001)
10.1002/BDD.511
Biodistribution of liposome‐entrapped human gamma‐globulin
María A García-Santana (2006)
10.1016/b978-0-12-384931-1.00016-7
P
J. Lackie (2013)
10.1016/0304-4157(88)90025-1
Reverse micelles as hosts for proteins and small molecules.
P. Luisi (1988)
10.1016/j.vaccine.2010.01.011
Chitosan-based nanoparticles for improving immunization against hepatitis B infection.
C. Prego (2010)
10.1016/j.colsurfb.2011.10.029
Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer.
K. Choi (2012)
10.1111/j.1432-1033.1972.tb19710.x
Fate of protein-containing liposomes injected into rats. An approach to the treatment of storage diseases.
G. Gregoriadis (1972)
10.1016/J.ADDR.2007.10.010
Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies.
C. Pouton (2008)
10.1016/S1350-4177(98)00027-3
Emulsification by ultrasound: drop size distribution and stability.
B. Abismaı̈l (1999)
10.2217/nnm.12.141
Orally delivered salmon calcitonin-loaded solid lipid nanoparticles prepared by micelle-double emulsion method via the combined use of different solid lipids.
Chunhui Chen (2013)
10.1080/08982100600680667
Effect of Diglucosamine on the Entrapment of Protein into Liposomes
S. Murakami (2006)
10.1016/0378-5173(95)04388-8
Thymopentin in solid lipid nanoparticles
S. Morel (1996)
10.1002/jps.22054
Delivery of therapeutic proteins.
D. Pisal (2010)
10.7508/ARI.2013.02.008
DESIGN AND EVALUATE ALGINATE NANOPARTICLES AS A PROTEIN DELIVERY SYSTEM
S. M. Bidhendi (2013)
Aerosol Liposomal Cyclosporine for Chronic Rejection in Lung Transplant 2174 Recipients
G C Smaldone (2006)
Nanopharmaceuticals (part 1): products on the 1361 market
V. Weissig (2014)
Method for producing solid lipid microspheres having a narrow size 1336 distribution, US5250236
M R Gasco (1993)
Oral peptide delivery: technology landscape & current 2101 status
L. N. Hassani (2015)
10.1515/9783111548050-024
M
M. Sankar (1824)
10.1016/0168-3659(91)90098-X
Nanoparticles as carriers for growth hormone releasing factor
J. Grangier (1991)
10.1016/S0076-6879(09)65015-1
Mucosal delivery of liposome-chitosan nanoparticle complexes.
E. Carvalho (2009)
10.1073/pnas.151247498
TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors
V. Torchilin (2001)
10.1038/nbt1184-979
Dehydration-Rehydration Vesicles: A Simple Method for High Yield Drug Entrapment in Liposomes
C. Kirby (1984)
10.1007/s10989-005-9010-3
Development and Comparison of Different Nanoparticulate Polyelectrolyte Complexes as Insulin Carriers
B. Sarmento (2005)
10.1023/A:1016015803611
Polyester Nanocapsules as New Topical Ocular Delivery Systems for Cyclosporin A
P. Calvo (2004)
10.1016/J.CARBPOL.2008.09.018
Structural analysis and properties of dextran produced by Leuconostoc mesenteroides NRRL B-640
R. K. Purama (2009)
10.5772/17020
Characterization and Properties of Chitosan
E. Alvarenga (2011)
Chitosan based drug delivery systems
A. Piegat (2016)
Solid lipid nanoparticles: production, characterization and 1549 applications
W Mehnert (2001)
10.1023/A:1024470508758
Visualization of Insulin-Loaded Nanocapsules: In Vitro and in Vivo Studies After Oral Administration to Rats
H. Pinto-Alphandary (2004)
10.1016/0168-3659(90)90013-J
Nanocapsules as carriers for oral peptide delivery
C. Damgé (1990)
10.1111/j.2042-7158.1991.tb05437.x
The effect of site of administration in the gastrointestinal tract on the absorption of insulin from nanocapsules in diabetic rats.
C. Michel (1991)
10.1002/(SICI)1097-4636(19991215)47:4<568::AID-JBM14>3.0.CO;2-X
Study of the mechanism of insulin encapsulation in poly(isobutylcyanoacrylate) nanocapsules obtained by interfacial polymerization.
M. Aboubakar (1999)
10.1016/S0378-5173(97)00083-5
Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers
P. Calvo (1997)
10.1016/0378-5173(93)90013-6
Preparation of submicron drug particles in lecithin-stabilized o/w emulsions. II. Characterization of cholesteryl acetate particles
B. Sjoestroem (1993)
10.1016/J.IJPHARM.2007.03.009
Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization.
J. Liu (2007)
10.1016/j.jconrel.2016.10.002
The interaction of protamine nanocapsules with the intestinal epithelium: A mechanistic approach.
Lungile Nomcebo Thwala (2016)
10.1007/s12291-013-0325-0
An Investigation into the Parameters Affecting Preparation of Polybutyl Cyanoacrylate Nanoparticles by Emulsion Polymerization
H. E. Shahmabadi (2013)
10.1016/S0168-3659(97)00196-X
Formulation of L-asparaginase-loaded poly(lactide-co-glycolide) nanoparticles: influence of polymer properties on enzyme loading, activity and in vitro release.
M. M. Gasper (1998)
10.1038/nrd4363
Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies
S. Mitragotri (2014)
10.4155/tde.13.104
Basics and recent advances in peptide and protein drug delivery.
Benjamin J. Bruno (2013)
10.1016/J.PROENG.2011.11.056
Effect of Temperature on Emulsion Polymerization of n-Butyl Acrylate
Guangfeng Wu (2011)
10.1016/j.ejps.2010.09.008
PLGA:poloxamer blend micro- and nanoparticles as controlled release systems for synthetic proangiogenic factors.
Yolanda Parajó (2010)
2018 Review on polyelectrolyte complex as novel approach for drug delivery system
S. L. Patwekar (2016)
Preparation of submicron drug particles in lecithin-stabilized 1532
B Sjöström
Visualization of 1784 insulin-loaded nanocapsules: in vitro and in vivo studies after oral administration to rats
H. Pinto-Alphandary (2003)
1897 Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications
C. Vauthier
Preparation and characterization of a peptide containing w/o 1647 emulsion
T. Trenktrog
10.2217/nnm.10.126
Self-nanoemulsifying drug delivery systems: formulation insights, applications and advances.
A. Date (2010)
Surface-modified P(HEMA- 1944 co-MAA) nanogel carriers for oral vaccine delivery: design
M. Durán-Lobato (2014)
1644 Effective incorporation of insulin in mucus permeating self-nanoemulsifying drug delivery 1645 systems
T. Karamanidou (2015)
10.1080/10717540701606483
Preparation and In Vitro Evaluation of bFGF-Loaded Chitosan Nanoparticles
M. Cetin (2007)
10.1016/j.jcis.2010.07.027
Using jet mixing to prepare polyelectrolyte complexes: complex properties and their interaction with silicon oxide surfaces.
Caroline Ankerfors (2010)
10.1016/j.actbio.2016.01.011
Targeted intracellular protein delivery based on hyaluronic acid-green tea catechin nanogels.
Kun Liang (2016)
10.1016/j.nano.2009.05.009
Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells.
R. K. Das (2010)
10.4155/tde.14.5
Recent developments in protein and peptide parenteral delivery approaches.
Ashaben Patel (2014)
10.1002/(SICI)1098-2299(200002)49:2<109::AID-DDR4>3.0.CO;2-#
Insulin‐loaded nanocapsules for oral administration: In vitro and in vivo investigation
M. Aboubakar (2000)
10.15406/JNMR.2015.02.00018
Gelatin Nanoparticles as a Delivery System for Proteins
Reena Kaintura (2015)
10.1016/J.IJPHARM.2006.07.026
Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin.
N. Zhang (2006)
Study of the inactivation process of the tetanus toxoid in contact with poly(lactic/glycolic acid) degrading microspheres
M. Tobío (1998)
Zheng
C. Zheng (2006)
10.1002/(SICI)1097-4636(199810)42:1<45::AID-JBM7>3.0.CO;2-O
Protein encapsulation within polyethylene glycol-coated nanospheres. I. Physicochemical characterization.
P. Quellec (1998)
10.1166/JCSB.2012.1020
Preparation, Characterization and Applications of Liposomes: State of the Art
A. Laouini (2012)
10.1016/j.xphs.2016.09.029
Polyarginine Nanocapsules as a Potential Oral Peptide Delivery Carrier.
G. Lollo (2017)
10.1163/1568562041753098
Design and characterisation of new nanoparticulate polymer blends for drug delivery
N. Csaba (2004)
10.1016/j.jconrel.2008.02.007
Design and production of nanoparticles formulated from nano-emulsion templates-a review.
N. Anton (2008)
10.1021/MA060230J
Formation of New Glucomannan−Chitosan Nanoparticles and Study of Their Ability To Associate and Deliver Proteins
M. Alonso-Sande (2006)
10.1016/B978-0-12-384935-9.10001-X
An Overview of the Field of Peptide and Protein Delivery
C. F. Walle (2011)
10.1016/S0378-5173(97)04885-0
Peptide-loaded solid lipid nanoparticles (SLN) : influence of production parameters
A. J. Almeida (1997)
10.1021/bm401141u
Development of PLGA-mannosamine nanoparticles as oral protein carriers.
M. Alonso-Sande (2013)
Preparation and in 2043 M AN US CR IP T AC CE PT ED ACCEPTED MANUSCRIPT 60 vitro evaluation of bFGF-loaded chitosan nanoparticles
M. Cetin (2007)
Preparation, characterization, and biodistribution study of technetium-99m-labeled 1508 leuprolide acetate-loaded liposomes in ehrlich ascites tumor-bearing mice
(2004)
coated liposomes for oral protein drug delivery Kowapradit
N Chitosan
Process for the preparation of dispersible colloidal 1714 systems of a substance in the form of nanocapsules
J. P. Devissaguet (1991)
10.1039/C6TB00308G
Polymer-based nanoparticles for protein delivery: design, strategies and applications.
H. Zhao (2016)
10.1007/BF02442596
Chitosan-dextran sulfate nanoparticles for delivery of an anti-angiogenesis peptide
Y. Chen (2006)
10.1021/JS980235X
Application of surface-coated liposomes for oral delivery of peptide: effects of coating the liposome's surface on the GI transit of insulin.
K. Iwanaga (1999)
10.1080/10717540490265243
The Effect of Different Lipid Components on the In Vitro Stability and Release Kinetics of Liposome Formulations
M. Anderson (2004)
10.1021/acs.chemrev.5b00346
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release.
Nazila Kamaly (2016)
10.1007/s11095-005-9175-7
Novel Mucosal Insulin Delivery Systems Based on Fusogenic Liposomes
T. Goto (2005)
10.1080/19420862.2015.1125583
Antibodies to watch in 2016
J. Reichert (2016)
10.3390/md8041305
Chitosan Based Polyelectrolyte Complexes as Potential Carrier Materials in Drug Delivery Systems
J. Hamman (2010)
1722 Chitosan-PEG nanocapsules as new carriers for oral peptide delivery: effect of chitosan 1723 pegylation degree
C. Prego (2006)
Pharmaceutical cyclosporin formulation 1526 with improved biopharmaceutical properties
L. J. Penkler (2003)
Process for the preparation of dispersible colloidal systems of a substance in the form of nanocapsules
J. P. Devissaguet (1991)
Hyaluronic acid nanocapsules for the intracellular delivery of anticancer drugs
A. C. Pires (2016)
FDA’s regulatory science program for generic PLA/PLGA-based drug products
Y. Wang (2016)
10.2217/nnm.14.10
Highly versatile immunostimulating nanocapsules for specific immune potentiation.
Sara Vicente (2014)
Len N
W. Blair Geho (2014)
Protein 1341 encapsulation within polyethylene glycol-coated nanospheres
P. Quellec (1998)
10.1016/j.bbrc.2010.03.041
Investigation of archaeosomes as carriers for oral delivery of peptides.
Z. Li (2010)
10.1046/j.1365-4362.36.s1.2.x
Bioavailability and pharmacokinetics of cyclosporine formulations: Neoral® vs Sandimmune®
M. G. Choc (1997)
10.1080/02652040110081406
The effect of oral absorption enhancers on the in vivo performance of insulin-loaded poly(ethylcyanoacrylate) nanospheres in diabetic rats
M. A. Radwan (2002)
10.1016/j.addr.2016.01.010
Oral delivery of macromolecular drugs: Where we are after almost 100years of attempts.
E. Moroz (2016)
10.1023/A:1011922819926
Stealth PLA-PEG Nanoparticles as Protein Carriers for Nasal Administration
M. Tobío (2004)
Liposomes: an overview of manufacturing techniques.
M. Mozafari (2005)
10.3109/10717544.2010.509357
Hyaluronic acid/Chitosan nanoparticles as delivery vehicles for VEGF and PDGF-BB
Yolanda Parajó (2010)
10.1155/2014/683153
Cyclosporine A Loaded PLGA Nanoparticles for Dry Eye Disease: In Vitro Characterization Studies
Vijay D. Wagh (2014)
10.1016/j.ijpharm.2010.03.061
Silica nanoparticle coated liposomes: a new type of hybrid nanocapsule for proteins.
Vellore J. Mohanraj (2010)
10.1155/2013/536291
Bovine serum albumin-loaded chitosan/dextran nanoparticles: preparation and evaluation of ex vivo colloidal stability in serum
Haliza Katas (2013)
10.1002/mabi.201300114
Hyaluronic acid nanohydrogels as a useful tool for BSAO immobilization in the treatment of melanoma cancer cells.
E. Montanari (2013)
10.1016/J.EXPPARA.2006.07.002
Leishmania major: immune response in BALB/c mice immunized with stress-inducible protein 1 encapsulated in liposomes.
A. Badiee (2007)
10.1016/j.ijpharm.2014.10.059
Administration strategies for proteins and peptides.
D. Ibraheem (2014)
10.1023/A:1012128907225
Chitosan and Chitosan/Ethylene Oxide-Propylene Oxide Block Copolymer Nanoparticles as Novel Carriers for Proteins and Vaccines
P. Calvo (2004)
10.1016/j.colsurfb.2013.07.019
An integrated buccal delivery system combining chitosan films impregnated with peptide loaded PEG-b-PLA nanoparticles.
Concetta Giovino (2013)
10.1016/j.biomaterials.2013.11.001
Enzyme delivery using the 30Kc19 protein and human serum albumin nanoparticles.
Hong Jai Lee (2014)
10.1016/S0927-7765(02)00053-X
Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules
M. Garcia-Fuentes (2003)
Study of the 1699 mechanisms of formation of nanoparticles and nanocapsules of polyisobutyl-2- 1700 cyanoacrylate
M. Gallardo
Chitosan-dextran sulfate nanoparticles for delivery of an 2071 anti-angiogenesis
Y. Chen (2003)
1764 Chitosan-based nanoparticles for improving immunization against hepatitis B infection
C. Prego (2010)
In vitro 1520 lipolysis tests on lipid nanoparticles: comparison between lipase/co-lipase and pancreatic 1521 extract
V. Jannin (2015)
10.1208/ps060105
Preparation, characterization, and biodistribution study of technetium-99m-labeled leuprolide acetate-loaded liposomes in ehrlich ascites tumor-bearing mice
N. Arulsudar (2008)
10.1056/NEJMOA043204
A randomized trial of inhaled cyclosporine in lung-transplant recipients.
A. Iacono (2006)
10.1016/j.chemphyslip.2013.10.011
Novel methods for liposome preparation.
Yogita P Patil (2014)
10.1515/9783111697888-007
E
Adam S. Opalski (1824)
10.2165/11204910-000000000-00000
Mifamurtide: a review of its use in the treatment of osteosarcoma.
J. Frampton (2010)
10.4172/2155-952X.1000276
Liposomes for Drug Delivery
Durgavati Yadav (2017)
Papahadjopoulos- 1480 sternberg
T. Wang (2010)
Self-nanoemulsifying drug delivery systems: 1631 formulation insights
A. A. Date (2010)
Polyelectrolyte biomaterial 1995 interactions provide nanoparticulate carrier for oral insulin delivery
C P Reis (1996)
Pharmaceutical cyclosporin formulation with improved biopharmaceutical properties
L. J. Penkler (2003)
10.1111/j.1745-7254.2006.00424.x
In vitro and in vivo evaluation of a novel oral insulin formulation
Er-li Ma (2006)
10.1615/CRITREVTHERDRUGCARRIERSYST.V19.I2.10
Nanocapsule technology: a review.
P. Couvreur (2002)
10.1016/J.JFOODENG.2012.08.009
Comparing droplet breakup for a high-pressure valve homogeniser and a Microfluidizer for the potential production of food-grade nanoemulsions
Laura J. Lee (2013)
10.1208/pt060360
A preliminary pharmacokinetic study of liposomal leuprolide dry powder inhaler: A technical note
Aliasgar Shahiwala (2008)
10.1016/S0378-5173(97)00249-4
W/O/W multiple emulsions of insulin containing a protease inhibitor and an absorption enhancer: preparation, characterization and determination of stability towards proteases in vitro
A. Silva-Cunha (1997)
N. chitosan coated liposomes for oral protein drug delivery Kowapradit, JariyaMethylated
A. Apirakaramwong (2012)
10.1166/JBN.2009.022
Insulin-loaded PLGA nanoparticles for oral administration: an in vitro physico-chemical characterization.
M. J. Santander-Ortega (2009)
Polymer-based nanoparticles for 1960 protein delivery: design
H. Zhao (2016)
10.1021/mp1001262
Nanoparticles based on PLGA:poloxamer blends for the delivery of proangiogenic growth factors.
I. d'Angelo (2010)
10.1126/SCIENCE.284.5417.1143
Polymersomes: tough vesicles made from diblock copolymers.
B. Discher (1999)
10.1016/S0264-410X(99)00313-8
Improved immunogenicity of a core-coated tetanus toxoid delivery system.
M. Tobío (1999)
10.1111/j.1365-2265.1993.tb00990.x
Pharmacokinetics of 1‐deamino‐8‐d‐arginine vasopressin after various routes of administration in healthy volunteers
A. Fjellestad-Paulsen (1993)
10.1186/1472-6750-2-9
Protein encapsulation in liposomes: efficiency depends on interactions between protein and phospholipid bilayer.
Jacques-Philippe Colletier (2002)
10.1016/j.addr.2016.04.001
Lipid-based nanocarriers for oral peptide delivery.
Zhigao Niu (2016)
10.1097/00001813-200008000-00006
Inhalational interleukin-2 liposomes for pulmonary metastases: a phase I clinical trial
K. Skubitz (2000)
10.1155/2013/848043
Formulation Strategies to Improve the Bioavailability of Poorly Absorbed Drugs with Special Emphasis on Self-Emulsifying Systems
S. Gupta (2013)
10.1186/1477-3155-8-18
Fabrication of PLGA nanoparticles with a fluidic nanoprecipitation system
Hui Xie (2010)
10.1016/j.jcis.2015.05.037
Tuneable stability of nanoemulsions fabricated using spontaneous emulsification by biopolymer electrostatic deposition.
A. H. Saberi (2015)
10.1039/C0SM00549E
Edible nanoemulsions: fabrication, properties, and functional performance
D. J. Mcclements (2011)
10.1016/J.PROGPOLYMSCI.2006.06.001
Chitin and chitosan: Properties and applications
M. Rinaudo (2006)
10.1016/j.jconrel.2013.09.012
Co-delivery of viral proteins and a TLR7 agonist from polysaccharide nanocapsules: a needle-free vaccination strategy.
Sara Vicente (2013)
10.1515/9783111576855-009
D
Saskia Bonjour (1824)
Nanoparticulate delivery system for 1998 insulin: design
C. P. Reis (2007)
Bernkop-Schnürch, In vivo 1394 evaluation of an oral self-microemulsifying drug delivery system (SMEDDS) for leuprorelin
F Hintzen
A 2122 Single-blind, Placebo-controlled, Dose-ranging Trial of Oral Hepaticdirected Vesicle Insulin 2123 Add-on to Oral Antidiabetic Treatment in Patients With Type 2 Diabetes Mellitus
Blair Geho
1679 V
L. N. Thwala (2016)
Microencapsulated 2141 chitosan nanoparticles for pulmonary protein delivery: In vivo evaluation of insulin-loaded 2142 formulations
S. Al-Qadi (2012)
The role of 1807 PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following 1808 oral administration
M Alonso
Nanoparticles as carriers for 58 growth hormone releasing factors (GRF)
J. L. Grangier (1991)
10.1016/j.ejps.2008.01.013
Protein delivery using nanoparticles based on microemulsions with different structure-types.
A. Graf (2008)
10.2147/IJN.S55359
Nanotherapeutics in the EU: an overview on current state and future directions
A. Hafner (2014)
10.1016/j.ejpb.2010.07.010
Layer-by-layer surface modification of lipid nanocapsules.
Samuli Hirsjärvi (2010)
Gelatin nanoparticles as a delivery 2086 system for proteins
R. Kaintura (2015)
10.1515/9783111576855-016
K
Martin P. Catherwood (1824)
10.1016/j.ejpb.2009.06.004
Formulation and characterization of an oily-based system for oral delivery of insulin.
A. Elsayed (2009)
Edible nanoemulsions: fabrication
D. J. McClements (2011)
10.1016/B978-0-12-416020-0.00001-2
Liposomes and other vesicular systems: structural characteristics, methods of preparation, and use in nanomedicine.
E. Elizondo (2011)
10.1515/9783486731620-002
I
John B. Shoven (1824)
10.1016/j.addr.2016.02.011
Oral delivery of diabetes peptides - Comparing standard formulations incorporating functional excipients and nanotechnologies in the translational context.
H. R. Lakkireddy (2016)
Improved 1877 immunogenicity of a core-coated tetanus toxoid delivery system, Vaccine
M Tobío (1999)
10.1016/0166-6622(88)80173-2
Spontaneous Emulsification Produced by Diffusion — A Review
C. Miller (1988)
10.1515/9783111419787-003
H
Yu-Qin Cao (1824)
In vitro and in vivo evaluation of a novel oral insulin 1405 formulation
E. Ma (2006)
Formation of nanoemulsions stabilized by model food-grade 1616 emulsifiers using high-pressure homogenization: factors affecting particle size, Food 1617 Hydrocoll
C Qian (2011)
Preparation and characterization of solid lipid nanoparticles 1538 containing peptide
F. Q. Hu (2004)
Nanoparticles based on PLGA: poloxamer blends for the delivery of 1839 proangiogenic growth
I. D’Angelo (2010)
10.1080/03639040802130061
Lipid Nanoparticles with a Solid Matrix (SLN®, NLC®, LDC®) for Oral Drug Delivery
M. Muchow (2008)
10.1016/j.ijpharm.2013.04.047
Oral delivery of oil-based formulation for a novel synthetic cationic peptide of GnRH (gonadotropin-releasing hormone) antagonist for prostate cancer treatment.
G. Zhang (2013)
10.1016/j.jconrel.2010.10.029
Release and bioactivity of PACA nanoparticles containing D-Lys⁶-GnRH for brushtail possum fertility control.
Alexandra P Kafka (2011)
10.1111/j.2042-7158.1994.tb03854.x
Calcitonin and insulin in isobutylcyanoacrylate nanocapsules: protection against proteases and effect on intestinal absorption in rats.
P. J. Lowe (1994)
10.2217/NNM-2016-0265
Lipid-based nanocarriers for the oral administration of biopharmaceutics.
T. Karamanidou (2016)
10.1016/J.ADDR.2007.04.007
Solid lipid nanoparticles as a drug delivery system for peptides and proteins.
A. Almeida (2007)
10.1023/A:1011998014474
Hydrophobic Ion Pairing: Altering the Solubility Properties of Biomolecules
J. D. Meyer (2004)
10.6091/IBJ.1242.2013
Producing gelatin nanoparticles as delivery system for bovine serum albumin.
B. Azimi (2014)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar